West Indies pace sensation Shamar Joseph will miss ILT20 because of a toe injury. He did well with a match-winning spell of 7 for 68 in the 2nd innings of the 2nd Test match at Gabba, Brisbane against Australia. He suffered an injury while facing a yorker against Mitchell Starc on the 3rd night. His brilliant spell of 7 for 68 helped West Indies stun Australia to win their first Test match on Australian soil after a gap of 27 years.
He will head home directly to recover from the toe injury that he suffered during the second Test match at Brisbane. Shamar’s injury was too serious that he will not take part in the International League T20 tournament that is currently going on in Dubai. Joseph was supposed to play for Dubai Capitals in 2nd edition.
“It is a balance. Look at Alzarri Joseph, he’s in the IPL and he has a lot of heart for Test cricket. He wants to be here. Today he was tired and he still came in those last two overs at the tail. Once you have a love for this game and this hard Test cricket, the right balance is key. I do believe we should be playing more Test cricket more consistently. Our next Test series is July 10, which is a long while away. So I believe we have talent and it shows the world that we are going to be competitive and win Test matches. But we need more cricket, and that’s my cry.”
Shamar Joseph’s Brilliant Debut Series
Shamar Joseph made his Test debut in the first match against Australia at Adelaide Oval. He proved his worth with a quickfire 36 in the first innings that helped West Indies post 188. Joseph showed his class picking his maiden five-wicket haul ending with figures of 5 for 94.
Joseph showed his character with some lovely bowling efforts in the second innings of the 2nd Test match at Gabba, Brisbane. He grabbed the wickets of Cameron Green, Travis Head, Mitchell Marsh, Alex Carey, Mitchell Starc, and Pat Cummins. Joseph ended the match getting the wicket of Josh Hazlewood to register a famous victory and level the series at 1-1.
Get the latest cricket news here, like us on Facebook, and follow us on Twitter and Instagram for more such updates.
